Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

N-[4-[[(2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-D-gamma-glutamyl-(2S)-2-amino-beta-alanyl-L-alpha-aspartyl-L-cysteine and folic acid

EU orphan designation number: EU/3/12/958
Active ingredient: N-[4-[[(2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-D-gamma-glutamyl-(2S)-2-amino-beta-alanyl-L-alpha-aspartyl-L-cysteine and folic acid
Indication: Diagnosis of positive folate receptor status in ovarian cancer
Sponsor: Endocyte Europe B.V.
Prins Bernhardplein 200, NL-1097 JB Amsterdam, Nederland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/02/2012 Centralised Orphan - Designation EMA/OD/095/11 (2012)884 of 09/02/2012
10/09/2012 Centralised Orphan - Removal of orphan designation from Community Register